Preliminary results

The project identified two prominent immunological signatures in the blood of Covid-19 patients that could be used to identify the patients most likely to do worse and require additional treatment.


We are in the news!!

Blood test could track immune response to COVID-19

The COVID-IP project has gathered huge media attention. Read the stories here:


Helping to find a Vaccine & Treatment for COVID-19

The Covid-IP Project Will Help Understand Our Immune Response To The Disease.

This week’s RELAXBACK UK SHOW hosted by Mike Dilke on UK Health Radio has Professor Adrian Hayday explaining the COVID-IP project he is running to understand more about the human response to the Covid-19 disease.

Hear about his work & thoughts on the future of combatting the disease.


COVID-19 immunology research: what do we know and what are the priorities?

How much do antibodies provide future protection against Covid-19? How long might immunity last, and what do we know about reinfection? What vaccine research is underway?

Professor Adrian Hayday, senior group leader at The Francis Crick Institute and King’s College London, joins the taskforce of 15 leading immunology experts in the fight against COVID-19 in this report by The Academy of Medical Sciences and the British Society for Immunology to try to answer some of these questions.

Scientific investigation of the COVID-19 disease is unprecedented and based on a remarkable mobilisation of international expertise and data sharing. Understanding our immunological responses to SARS-CoV-2 virus will help us develop successful treatments and vaccines, identify vulnerable groups and inform public health measures to control COVID-19 outbreaks. This new expert summary aims to help researchers, funders and policymakers navigate the existing research findings; and identifies urgent research priorities that will make the biggest difference to patients and society, whilst highlighting knowledge gaps that could hamper efforts to get the pandemic under control.

To read more about this please visit here.